Lixte Biotechnology and City of Hope Enroll First Patient in Phase 1b Trial of Lead Compound LB ...

Retrieved on: 2021-06-02 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

Lixte Biotechnology and City of Hope Enroll First Patient in Phase 1b Trial of Lead Compound LB .... View article details on hiswai:

Excerpt

EAST SETAUKET, NY, June 02, 2021 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery ...

Article found on: www.globenewswire.com